THE DNA MEDICINE INSTITUTE, INC.
Cambridge, MA · Medtech · Private
Point-of-care FVIII activity monitoring device with fluorogenic substrate assay cartridge and companion app for hemophilia A patients
dnamedinstitute.com →- Grants
- $1.5M
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $7.1M
- 12 awards · NASA, Health and Human S, Defense
- #91 of 4531 in medtech
- Patents
- 1
- 1 granted · 0 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | National Aeronautics and Space Administration · Reusable Handheld Electrolytes And Lab Technology For Humans (rhealth Sensor) The Goal Of The Rhealth Sensor Is To Provide Rapid, Low-cost, Handheld Complete Blood Count (cbc), Cell Differential Counts, Electrolyte Measurements, And Other Lab Tests Based On A Reusable, Flow-based Microfluidic Platform. For Phase II, We Will Develop An Rhealth Prototype To Be Delivered To NASA For Reusable Cbc, Cell Differential Counts, And Electrolyte Measurements. Each Subassembly And Individual Assay Will Be | $749,950 | |
| Federal contract | National Aeronautics and Space Administration · The Goal Of Our Nanoscale Test Strips, Or Nanostrips, Is To Provide Rapid, Low-cost, Powerful Multiplexed Analyses In A Diminutive Form So That Whole Body Health Checks Can Be Performed On A Single Drop Of Blood. The Approach Is Conceptually Similar To Ph Or Urinalysis Test Strips Which Allow Multiple Measurements In A Linear Format. The Main Difference Is That We Are Proposing Test Strips At The Nanoscale, Shrunk In Size Over 100,000-FOLD In Surface Area, Allowing Multiple Sensing Elements To B | $99,997 | |
| Federal contract | National Aeronautics and Space Administration · The Goal Of Our Nanoscale Test Strips, Or Nanostrips, Is To Provide Rapid, Low-cost, Powerful Multiplexed Analyses In A Diminutive Form So That Whole Body Health Checks Can Be Performed On A Single Drop Of Blood. The Approach Is Conceptually Similar To Ph Or Urinalysis Test Strips Which Allow Multiplexed Measurements In A Linear Format. The Main Difference Is That We Are Proposing Test Strips At The Nanoscale, Shrunk In Size Over A Billion-fold In Volume, Allowing Multiple Sensing Elements To Be | $749,998 | |
| Federal contract | National Aeronautics and Space Administration · Sap Purchase Requisition: 4200358122 Based On The Successful Work In Progress Under A Pair Of Phase II Sbirs Led By Dr. Eugene Chan, Nasa/jsc S Human Research Program (hrp) Identified The Rhealth Sensor As The Leading Candidate For Performing Blood And Urine Analysis On The International Space Station (iss). It Will Directly Impact All Biomedical Research On Iss, And It May Also Play A Critical Role In Medical And Environmental Monitoring. The Successful Deployment Of Rhealth On Iss Addresses In | $190,000 | |
| Federal contract | National Aeronautics and Space Administration · SBIR Phase III Award | $419,350 | |
| Federal contract | National Aeronautics and Space Administration · Igf::ot::igf Award Is For Follow-on Work For SBIR III Contract. The Dna Medicine Institute (dmi) Shall Develop The Rhealth Biosensor, Its Sample Acquisition Protocol, And Supporting Reagents As Needed To Evaluate The Rhealth System Performance Against Measurements Of A Recognized Medical Standard. To Date, The Principal Investigator (pi) Has Demonstrated Feasibility Of Counting White Blood Cells In The Rhealth System, And Has Completed Final Report Detailing White Blood Cell Limited Clinical Va | $949,341 | |
| Federal contract | National Aeronautics and Space Administration · Igf::ot::igf There Is An Extraordinary Need For A Universal Biomedical Analyzer That Has Broadly Flexible Capabilities For Cell Studies, Small Animal Experiments, And Crew Member Health. The Goal Of Our Rhealth X Device Is To Create A Single Palmsized Device With Tripartite Capabilities: Non-invasive Measurements, Cell Cytometry Analysis, And Multiplexed Nanostrip Tests. Currently, There Is No Single Device That Is Able To Provide Comprehensive Non-invasive Measurements, Let Alone Combine It Wit | $123,425 | |
| Federal contract | National Aeronautics and Space Administration · Igf::ot::igf There Is An Extraordinary Need For A Universal Biomedical Analyzer That Has Broadly Flexible Capabilities For Cell Studies, Small Animal Experiments, And Crew Member Health. The Goal Of Our Rhealth X Device Is To Create A Single Palm-sized Device With Tripartite Capabilities: Non-invasive Measurements, Cell Cytometry Analysis, And Multiplexed Nanostrip Tests. Currently, There Is No Single Device That Is Able To Provide Comprehensive Non-invasive Measurements, Let Alone Combine It Wi | $900,000 | |
| Federal contract | National Aeronautics and Space Administration · Technical Objective #1 Reporting. Overall, We Plan To Have Routine Verbal And Written Communications With NASA And Afrl. This Will Include Quarterly Reports As Well As Teleconferences As Needed. Technical Objective #2 Vitals Strap Form Factor Design. We Will Need To Develop A Strap Design That Is Comparable In Terms Of Skin Contact And Positioning As The Gel-adhesive Currently Used With The Skye Sensor. In Particular, We Will Explore Various Strap Orientations To Arrive At A Design That Offers T | $150,000 | |
| Federal contract | National Aeronautics and Space Administration · There Is Extraordinary Need For A Universal Biomedical Analyzer That Has Broadly Flexible Capabilities For Diverse Biomedical Analysis. The Goal Of Our Rhealth X Device Is To Create A Single Palm-sized Device That Is Capable Of Cell Cytometry Measurements And Multiplexed Nanostrip Tests Across Diverse Assay Classes. It Works In Concert With Our Skye Sensor, A Monolithic Palm-sized Unit For Monitoring Of All Vitals, And Chas, An Intelligent App. Currently, There Is No Single Device That Is Able T | $1,999,994 | |
| Federal grant | Department of Health and Human Services · Phase II · FVIII Point-of-Care Monitoring Device and App | $1,473,927 | |
| Federal contract | Department of Health and Human Services · Dna Medicine Institute Will Design And Build A Low-cost And Disposable Flow Cell To Adapt Their Existing Space Flight Optical Cytometry Module Into A Low-cost Optical Module Solution, In Order To Make Cytometry More Accessible To Patients | $741,584 | |
| Federal contract | Department of Defense · Scalable Homeland Innovative Enterprise Layered Defense (shield) Initial Order. | $500 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 88 | BrainScope Company, Inc. | $7.5M | $27M |
| 89 | IRIDEX CORP | $7.5M | $10M |
| 90 | MATREGENIX INC | $7.1M | — |
| 91 | THE DNA MEDICINE INSTITUTE, INC. | $7.1M | — |
| 92 | AUXILIUM BIOTECHNOLOGIES INC. | $6.9M | $6.8M |
| 93 | Veracyte | $6.8M | $22M |
| 94 | SONIVATE MEDICAL, INC. | $6.7M | $1.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Multi-channel vitals devicegranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.